HLA Associations in Chronic Vision Threatening Uveitis

References

• Krieglstein G, Weinreb R, Pleyer U, Foster CS. Uveitis and Immunological Disorders. Berlin: Spinger/Verlag, 2007. pp 103–106
   Google Scholar
• Abi-Hanna D, Wakefield D, Watkins S. HLA antigens in ocular tissues. I. Transplantation 1988;45(3):610–613
   PubMedGoogle Scholar
• Zamecki K J, Jabs D. A HLA Typing in uveitis: use and misuse. Am J Ophthalmol 2010;149:189–193
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Mittal KK, Ryan S, et al. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol 1982;94(2):147–158
   PubMed Web of Science ®Google Scholar
• Feltkamp T E. HLA and uveitis. Int Ophthalmol 1990;14(5–6):327–333
   PubMedGoogle Scholar
• Foster CS, Vitale A. Diagnosis & Treatment of Uveitis. New Delhi: Jaypee Brothers Medical Publishers, 2013
   Google Scholar
• Ohno S, Ohguchi M, Hirose S, et al. Close association of HLA-Bw51 with Behçet’s disease. Arch Ophthalmol 1982;100:1455–1458
   PubMed Web of Science ®Google Scholar
• Mishima S, Masuda K, Izawa Y, et al. Behçet’s disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc 1979;76:225–279
   Google Scholar
• Raizman MB, Foster CS. Plasma exchange in the therapy of Behçet’s disease. Graefes Arch Clin Exp Ophthalmol 1989;227:360–363
   PubMed Web of Science ®Google Scholar
• Yazici H, Chamberlain MA, Schieuder I, et al. HLA antigens in Behçet’s disease: a reappraisal by a comparative study of Turkish and British patients. Ann Rheum Dis 1980;39:344–348
   PubMed Web of Science ®Google Scholar
• Zouboulis CC, Kotter I, Djawari D, et al. Epidemiological features of Adamntiades- Behçet’s disease in Germany and in Europe. Yonsei Med J 1997;38:411–422
   PubMedGoogle Scholar
• Zervas J, Vayopoulos G, Sakellaropoulos N, Kaklamanis P, Fessas P. HLA antigens and Adamantiades-Behçet’s disease (A-BD) in Greeks. Clin Exp Rheumatol 1988;6:277–280
   PubMedGoogle Scholar
• Ohno S, Char DH, Kimura SJ, et al. Studies on HLA antigens in American patients with Behçet’s disease. Jpn J Ophthalmol 1978;22:58–61
   Google Scholar
• O’Duffy JD, Taswell HF, Elveback LR. HL-A antigens in Behçet’s disease. J Rheumatol 1976;3:1–3
   PubMedGoogle Scholar
• Mizuki N, Inokoko H, Ando H, et al. Behçet’s disease associated with one of the HLA-B51 subantigens, HLA-B*5101. Am J Ophthalmol 1993;116:406–409
   PubMed Web of Science ®Google Scholar
• Koumantaki Y, Stavropoulos K, Spyropoulou M, et al. HLA-B*5101 in Greek patients with Behçet’s disease. Human Immunol 1998;59:250–255
   PubMed Web of Science ®Google Scholar
• Lehner T, Barnes CG. Criteria for diagnosis and classification of Behçet’s syndrome. In: Behçet’s Syndrome: Clinical and Immunological Features (Lehner T, Barnes CG, Eds.), Proceedings of a Conference Sponsored by Royal Society of Medicine, February 1979; London: Academic Press, 1979; 1–9
   Google Scholar
• Shindo Y, Inoko H, Yamamoto T, et al. HLA-DRBI typing of Vogt-Koyanagi-Harada disease by PCR-RFLP and the strong association with DRBI 0405. Br J Ophthalmol 1994;78:223–226
   PubMed Web of Science ®Google Scholar
• Weisz J, Holland G, Roer L, et al. HLA associations in Hispanic patients with Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci 1994;35(suppl):2097
   Google Scholar
• Zhao M, Jiang Y, Abrahams I. Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Arch Ophthalmol 1991;109:368–370
   PubMedGoogle Scholar
• Davis J, Mittal, KK, Freidlin, V. HLA association and ancestry in VKH and sympathetic ophthalmia. Ophthalmology 1990;97:1137–1142
   PubMed Web of Science ®Google Scholar
• Martin T, Weber M, Schmitt C, et al. Association of intermediate uveitis with HLA-A28: definition of a new systemic syndrome? Graefe’s Arch Clin Exp Ophthalmol 1995;233:269–274
   PubMedGoogle Scholar
• Tang WM, Pulido JS, Eckels DD, et al. The association of HLADR15 and intermediate uveitis. Am J Ophthalmol 1997;123:70–75
   PubMed Web of Science ®Google Scholar
• Raja SC, Jabs DA, Dunn JP, et al. Pars planitis: clinical features and class II HLA associations. Ophthalmology 1999;106:594–599
   PubMed Web of Science ®Google Scholar
• Oruc S, Duffy BF, Mohanakumar T, et al. The association of HLA class II with pars planitis. Am J Ophthalmol 2001;131:657–659
   PubMed Web of Science ®Google Scholar
• Mantrana-Bermejo ME, Rueda-Rueda T, Bernabeu-Wittel J, et al. Clinical and epidemiological features and HLA association in patients with pars planitis. Med Clin (Barc) 2010;135:205–208
   PubMedGoogle Scholar
• Greiner KH, Wilson DW, Thomson J, et al. Genetic polymorphism of HLA DR in a Scottish population of patients with pars planitis. Eur J Ophthalmol 2003;13:433–438
   PubMedGoogle Scholar
• Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol 2005; 50:364–368
   PubMed Web of Science ®Google Scholar
• Brewerton DA, Caffrey M, Hart FD, et al. Ankylosing spondylitis and HLA-B27. Lancet 1973;1:904–907
   PubMed Web of Science ®Google Scholar
• Rosenbaum JT. Characterization of uveitis associated with spondyloarthritis. J Rheumatol 1989;16:792–796
   PubMed Web of Science ®Google Scholar
• Tay Kearney ML, Schwam BL, Lowder C, et al. Clinical features and associated systemic disease of HLA-B27 uveitis. Am J Ophthalmol 1996;121:47–56
   PubMedGoogle Scholar
• Linssen A, Meenken C. Outcomes of HLA-B27–positive and HLAB27–negative acute anterior uveitis. Am J Ophthalmol 1995;120:351–361
   PubMed Web of Science ®Google Scholar
• Levinson RD, Park MS, Rikkers SM, et al. Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci 2003;44:653–657
   PubMed Web of Science ®Google Scholar
• American Academy of Ophthalmology. BCSC series section 9. Intraocular Inflammation and Uveitis. Singapore: Lifelong Education for the Ophthalmologist. 2009
   Google Scholar